Wei Liao

Title: Wei Liao: Innovator in Pharmaceutical Compounds

Introduction

Wei Liao is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating respiratory diseases. His innovative work has led to the creation of a unique pharmaceutical compound that holds promise for improving patient outcomes.

Latest Patents

Wei Liao holds a patent for an S-(carboxymethyl)-cysteine pharmaceutical compound and its preparation method and use. This patent discloses an S-(carboxymethyl)-cysteine pharmaceutical compound, along with a preparation method and its applications. The compound is particularly useful in the preparation of medicines for preventing and treating respiratory system diseases, such as chronic obstructive pulmonary disease (COPD). The invention has shown potential in reducing airway resistance and the production of oxides in rat COPD models, while also increasing antioxidant levels and alleviating lung damage caused by oxides and inflammatory mediators.

Career Highlights

Throughout his career, Wei Liao has worked with prominent organizations in the pharmaceutical industry. He has been associated with Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. and the Baiyunshan Pharmaceutical General Factory. His work in these institutions has allowed him to contribute to the advancement of respiratory disease treatments.

Collaborations

Wei Liao has collaborated with notable colleagues, including Mao Chen and Shaoxuan Zhu. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the pharmaceutical field.

Conclusion

Wei Liao's innovative contributions to pharmaceutical compounds demonstrate his commitment to improving healthcare solutions for respiratory diseases. His patent for S-(carboxymethyl)-cysteine highlights the potential for new treatments that can significantly benefit patients.